AI-Powered Healthcare Stocks to Watch: Recursion Pharmaceuticals and [Other Company]
ByAinvest
Tuesday, Mar 31, 2026 7:09 am ET1min read
RXRX--
Recursion Pharmaceuticals uses AI to virtually test drugs and reduce the $900 million cost of bringing a drug to market. Its platform analyzes 50 petabytes of data to predict a drug's performance. The company partners with pharma giants like Sanofi and Roche to develop third-party prospects. Recursion Pharmaceuticals is still in its early stages, but expects significant revenue growth next fiscal year.
![AI-Powered Healthcare Stocks to Watch: Recursion Pharmaceuticals and [Other Company]](https://cdn.ainvest.com/aigc/hxcmp/images/compress-1c4bc24097952002.png?format=webp&width=700)
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet